Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetic After Oral Administration of CKD-341 and D956 in Healthy Adults

• Status: COMPLETED
• Trial end date: 2024-05-14

Summary

The objective was to evaluate and compare the pharmacokinetic profiles and safety after administration of test drug (CKD-341) and reference drugs (D956) in healthy adults.

• Phase: PHASE1

Details

• Lead Sponsor: Chong Kun Dang Pharmaceutical
• Treatments: Tablets